POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease

Completed · Phase 2

Conditions studied: Parkinson's Disease

In brief

The primary objectives of the POETRY study are to assess the safety and tolerability of estrogen replacement therapy (ERT) in postmenopausal women with Parkinson's disease (PD) and to assess recruitment for a study of ERT in postmenopausal women with PD.

Key facts

Study ID

NCT00234676

Run by

The Parkinson Study Group

People needed

23

Starts

2003-10-01

Expected to finish

2006-03-01

Last updated by the study team

2008-01-08

Who can join

Age: any, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Post-menopausal women with Parkinson's disease who experience levodopa-related motor fluctuations averaging at least 2 hours daily in the "off" state confirmed by home diaries
• Must be on a stable dose of carbidopa/levodopa, immediate or controlled release therapy, antidepressants, or anxiolytics (for the last 30 days)

You may not qualify if…

• Insulin dependent diabetes
• Thyroid disease

Where it is running

• The Parkinson's Institute — Sunnyvale, California, United States
• Emory University — Atlanta, Georgia, United States
• Indiana University School of Medicine — Indianapolis, Indiana, United States
• University of Maryland — Baltimore, Maryland, United States
• University of Rochester — Rochester, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.